Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J AOAC Int ; 93(4): 1215-21, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20922954

RESUMO

A rapid, sensitive, and simple HPLC/MS/MS method was developed and validated for the determination of (5Z,E)-3-[2-(4-chlorophenyl)-2-oxoethyl]-5-(1H-indol-3-ylmethylene)-thiazolidine-2, 4-dione (PG15) in rat plasma using chlortalidone as an internal standard (IS). Analyses were performed using a C18 column and isocratic elution with acetonitrile-water (90 + 10, v/v) containing 10 mM ammonium hydroxide (pH 8.0) as the mobile phase pumped at 0.3 mL/min. Detection was performed by MS with negative ion mode electrospray ionization. Rat plasma samples were prepared by deproteinizing with acetonitrile. Detected fragments were 395.1 > 171.9 for PG15 and 337.3 > 189.9 for the IS. Calibration curves were linear from 10 to 1000 ng/mL, with the determination coefficient > 0.99. The intraday and interday precisions were less than 12.2 and 11.3%, respectively. The applicability of the HPLC/MS/MS method for pharmacokinetic studies was tested using plasma samples obtained after oral administration of PG15 to rats, and it provided the necessary sensitivity, linearity, precision, accuracy, and specificity.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Indóis/sangue , Espectrometria de Massas em Tandem/métodos , Tiazolidinas/sangue , Animais , Estabilidade de Medicamentos , Indóis/química , Ratos , Tiazolidinas/química
2.
J AOAC Int ; 93(6): 1856-61, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21313812

RESUMO

Entacapone is indicated for clinical use as an adjunct to levodopalcarbidopa to treat patients with idiopathic Parkinson's Disease who experience the signs and symptoms of end-of-dose wearing-off. The aim of this study was to determine the photodegradation kinetics and to elucidate the structure of the main degradation product. The stability of entacapone was studied in order to investigate the degradation kinetics of this drug using LC as a stability indicator. Entacapone was subjected to accelerated photodegradation. This study was carried out with methanolic solutions, prepared from coated tablets, in quartz cells under UV light at 254 nm. The degradation process of entacapone in solutions can be described by second-order kinetics under the experimental conditions used in this study. The LC/MS/MS determinations revealed that in the above conditions the photodegraded product formed the geometric isomer of entacapone (Z-entacapone). The obtained results show the importance of appropriate light protection during the drug development process, storage, and handling.


Assuntos
Antiparkinsonianos/química , Catecóis/química , Nitrilas/química , Antiparkinsonianos/análise , Antiparkinsonianos/efeitos da radiação , Varredura Diferencial de Calorimetria , Catecóis/análise , Catecóis/efeitos da radiação , Cromatografia Líquida de Alta Pressão , Estabilidade de Medicamentos , Isomerismo , Cinética , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Nitrilas/análise , Nitrilas/efeitos da radiação , Fotoquímica , Soluções , Espectrofotometria Infravermelho , Raios Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...